Table 2. Time-course experiment on LECs treated with high and intermediate levels of arsenite for 24 h.

		Volume (%) (mean)*
Spot no./identified protein	Arsenite (μM)	0 h	2 h	4 h	6 h	8 h	12 h	24 h
1. HSP70	20	ND	ND	0.125	0.253	0.280	0.340	0.402
	40	ND	ND	0.138	0.395	0.581	0.713	0.867
2. AR	20	0.178	0.189	0.201	0.378	0.486	0.502	0.603
	40	0.181	0.192	0.203	0.382	0.490	0.510	0.620
3. GAPDH	20	0.699	0.700	0.696	0.697	0.696	0.694	0.695
	40	0.702	0.695	0.694	0.686	0.682	0.484	0.147
4. HO-1	20	ND	ND	ND	ND	0.059	0.066	0.201
	40	ND	ND	ND	0.048	0.211	0.515	0.802
5. HSP27	20	0.087	0.112	0.128	0.193	0.208	0.267	0.332
	40	0.088	0.169	0.255	0.416	0.512	0.801	0.994
6. FLC	20	0.024	0.035	0.073	0.098	0.105	0.111	0.124
	40	0.025	0.052	0.109	0.147	0.158	0.162	0.187
7. αB-C (phosphorylated)	20	ND	ND	0.079	0.152	0.262	0.356	0.416
	40	ND	0.029	0.146	0.203	0.504	0.819	0.829
8. αB-C	20	0.391	0.404	0.412	0.497	0.712	0.747	0.764
	40	0.393	0.408	0.428	0.698	0.735	1.023	1.147

* Data are derived from Figures 3(A) and 3(B) and expressed as mean values for three independent analyses.